Low-dose Pfizer-BioNTech vaccine fails in trial on 2 to 5 year olds

Norge Nyheter Nyheter

Low-dose Pfizer-BioNTech vaccine fails in trial on 2 to 5 year olds
Norge Siste Nytt,Norge Overskrifter
  • 📰 FoxNews
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 87%

A low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two through five years of age.

The companies

A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic in the Norristown Public Health Center in Norristown, Pa., Tuesday, Dec. 7, 2021. "The companies will amend the clinical study evaluating the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age," the statement said.

Germaine T. Leftwich, 67, receives a Pfizer covid-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Safeway on Capitol Hill in Washington, D.C., on Monday, October 4, 2021.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

FoxNews /  🏆 9. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Pfizer and BioNTech ask FDA to approve their Covid-19 vaccine for kids as young as 12Pfizer and BioNTech ask FDA to approve their Covid-19 vaccine for kids as young as 12The companies submitted Phase III clinical trial data to FDA as a supplemental application for their vaccine, which is already approved for adults and children as young as 16.
Les mer »

Pfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include adolescents aged 12 to 15.
Les mer »

CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J ShotCDC Panel Recommends Pfizer, Moderna Vaccines Over J&J ShotU.S. health advisers are recommending that most Americans get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.
Les mer »

CDC panel recommends people not get J&J vaccine if Pfizer, Moderna availableCDC panel recommends people not get J&J vaccine if Pfizer, Moderna availablePeople shouldn’t get the Johnson & Johnson COVID-19 vaccine when the Pfizer-BioNTech and Moderna shots are available, an advisory panel to the CDC said.
Les mer »

CDC recommends people not get J&J vaccine if Pfizer, Moderna are availableCDC recommends people not get J&J vaccine if Pfizer, Moderna are availableThe advisory committee voted in favor of language that calls the mRNA vaccines from Pfizer and Moderna the 'preferred' options over Johnson & Johnson's.
Les mer »



Render Time: 2025-04-02 01:20:30